Preoperative anaemia is common in patients undergoing cardiac surgery. Whilst there is a strong association with increased morbidity and mortality, it is currently unclear whether treatment of anaemia leads to patient benefit. This retrospective study aimed to determine the aetiology of preoperative anaemia in a cohort of patients undergoing elective cardiac surgery over two years at a tertiary hospital. Laboratory data obtained at the preoperative assessment clinic visit were assessed to stratify patients into four groups-iron deficiency anaemia (IDA), possible IDA, anaemia of chronic disease (ACD) and non-anaemic patients with low ferritin according to the 'Preoperative haemoglobin assessment and optimisation template' of the Australian Patient Blood Management (PBM) Guidelines. Of patients with preoperative anaemia, 23.1% had IDA, 6.6% had possible IDA and 70.3% had possible ACD. Of the patients with possible ACD, 30% had a ferritin <100 µg/l, representing limited iron stores or coexisting absolute iron deficiency in the setting of chronic disease. In addition, 46.2% of those with possible ACD had iron studies indicative of functional iron deficiency. Time between assessment and surgery was as little as one day in a third of patients and in only 7% was it more than seven days. Our findings indicate that about one-third of our patients with preoperative anaemia had evidence of iron deficiency, a potentially reversible cause of anaemia. In addition, a significant number had either limited iron stores that may render them iron deficient by surgery, or a functional iron deficiency.
Introduction
Preoperative anaemia is common, with a previous study at our centre showing that a quarter of patients undergoing elective cardiac surgery had preoperative anaemia 1 . Although the relationship between preoperative anaemia and adverse outcomes is associative, there is a large and consistent body of evidence 2 . As outlined by recent British guidelines, there are distinct reasons why identification and management of preoperative anaemia should be considered important 2 . Firstly, it may be due to previously undiagnosed disease such as malignancy, detection of which carries a health benefit to the patient beyond the planned surgical episode. Secondly, to reduce the likelihood of transfusion and preserve a limited and donated resource. Thirdly, to avoid unnecessary exposure to potential adverse effects of anaemia, transfusion or both 1, [3] [4] [5] [6] [7] .
Anaemia management is one of the so-called 'three pillars'
of Patient Blood Management (PBM). These include 1) preoperative optimisation of red cell mass and coagulation status, 2) minimisation of perioperative blood loss, including meticulous attention to surgical haemostasis, and 3) tolerance of postoperative anaemia 8 . With regard to the first pillar, there is limited data as to the aetiology of preoperative anaemia in patients undergoing elective cardiac surgery. The perioperative module of the Australian PBM Guidelines (module 2) released in 2012 recommends that in patients undergoing cardiac surgery, preoperative anaemia should be identified, evaluated and managed to minimise red cell transfusion 8 . The Grade C recommendation reflects that whilst the body of evidence provides some support for the recommendation, care should be taken in its application. The PBM guidelines provide a 'preoperative haemoglobin assessment and optimisation template' for identification and evaluation of anaemia in patients scheduled for major surgery in whom substantial blood loss is anticipated. The aim of this retrospective observational study was to determine the aetiology of preoperative anaemia (PBM Guidelines, pillar one) utilising blood tests done routinely as a part of preoperative evaluation, and the prevalence of non-anaemic iron deficiency. Understanding the causes of anaemia could assist with resource planning when implementing PBM strategies and in the design of much needed prospective trials.
Methods
We undertook a retrospective audit of laboratory analyses for outpatients assessed in the cardiothoracic preoperative assessment clinic (POAC) scheduled for elective cardiac bypass or valve surgery at the Royal Adelaide Hospital, South Australia, a major tertiary hospital. The two-year study period was from July 2011 to June 2013. We excluded all patients who were not assessed in the POAC (e.g. inpatient referrals), those who underwent emergency cardiac surgery, and those with incomplete data. Ethics approval was granted by the Royal Adelaide Hospital and South Australian (SA) Department of Health Research Ethics Committees (Protocol Number 131006).
All patients were referred to the POAC by their respective cardiac surgeons and were assessed by the cardiothoracic anaesthetist. The routine preoperative workup included complete blood examination, serum ferritin, C-reactive protein (CRP) and renal function tests. Further assessment, investigation, and treatment of anaemia (if detected) was at the discretion of clinical staff and not part of this study. Assessment of adherence to locally agreed anaemia templates (during 2011) or the National PBM Guideline template (Module 2) released during 2012 was also not part of this study. This later template was used to retrospectively categorise the aetiology of anaemia based on the results of the routinely collected POAC blood tests.
The patient demographic details were obtained from the cardiac POAC database, including age, gender, and procedure (coronary artery bypass graft [CABG], valve repair or replacement, combined CABG and valve replacement or repair, and other). Laboratory data included haemoglobin (Hb), mean corpuscular volume (MCV) and mean corpuscular Hb (MCH) (Sysmex XE-2100, Sysmex Corporation, Japan), CRP (immunoassay using direct chemiluminometric technology [Siemens Advia 2400 chemistry system, Siemens Healthcare, Erlangen, Germany]); serum ferritin and transferrin saturation (TSAT) (Siemens Advia 2400 chemistry system, Siemens Healthcare, Erlangen, Germany); and estimated glomerular filtration rate (eGFR) calculated by the Chronic Kidney Disease Epidemiology collaboration equation where available 9 . The laboratory results obtained at the POAC visit were used for analysis. Anaemia was diagnosed if the Hb was <130 g/l in males and <120 g/l in females using World Health Organization (WHO) criteria 10 . Red cell indices MCH <27 picogram(pg)/cell and/or MCV <80 femtolitres(fl) were considered low.
Based on the template, patients were stratified into four categories: 1) iron deficiency anaemia (IDA) defined as anaemia with ferritin <30 µg/l, 2) 'possible iron deficiency anaemia' (possible IDA) defined as anaemia with ferritin 30-100 µg/l and CRP >8 mg/l, 3) 'possible anaemia of chronic disease/inflammation or other cause' (possible ACD) defined as anaemia with ferritin >100 µg/l, or anaemia with serum ferritin 30-100 µg/l and CRP <8 mg/l, and 4) no anaemia. Non-anaemic patients were classified into two groups, according to serum ferritin <30 µg/l and serum ferritin ≥30 µg/l. Further categorisation within the 'possible ACD' subgroup for other causes of anaemia (beyond assessment of renal function) was outside the scope of the study. Serum ferritin between 100-300 µg/l with TSAT <20% was considered consistent with functional iron deficiency 11 . 
Statistical analysis
All data are presented as median and interquartile range (IQR) or incidence (number, %). Statistical analysis was descriptive only.
Results

Patient characteristics
A total of 1,032 patients underwent cardiac surgery in the two-year period, with 462 of these referred to the cardiothoracic preoperative assessment clinic. Twenty patients were excluded from the analysis (eight due to incomplete data linkage, ten patients had surgery rescheduled or cancelled, and two had missing serum ferritin). The data obtained from the remaining 442 patients were analysed.
The median age of the cohort was 66 years (IQR 57-74 years) and 70% (307/442) were men. All patients underwent cardiopulmonary bypass during the surgery. Cardiac valve repair or replacement surgery was performed in 43% (189/442) and 39% (171/442) underwent coronary artery bypass graft surgery. Eighteen percent (82/442) of patients underwent combined valve and bypass graft surgery or other cardiac surgery which required cardiopulmonary bypass.
Interval between preoperative assessment and surgery
The time between preoperative assessment and surgery was short for many patients, with 30% seen the day prior and 67% seen three days or less before surgery ( Figure 1 ). Only 7% of patients had preoperative assessment more than seven days prior to surgery.
Prevalence and aetiology of anaemia
Preoperative anaemia was detected in 20.6% (91/442) of patients. When patients with preoperative anaemia were stratified according to the PBM template, initial analysis showed that 17 patients (19%) had serum ferritin <30 µg/l, 25 patients (27.5%) had serum ferritin between 30 µg/l and 100 µg/l, and 49 (53.8%) had serum ferritin >100 µg/l. Of the 25 patients with serum ferritin between 30 µg/l and 100 µg/l, six had a raised CRP and were further classified into possible IDA. The remaining 19 patients with normal CRP and the 49 patients with serum ferritin >100 µg/l were collectively classified as possible ACD according to the template. Further analysis revealed that four patients with serum ferritin >100 µg/l were diagnosed with IDA during earlier hospital admissions and received intravenous (IV) iron prior to POAC. We therefore regrouped them with the 17 IDA patients with serum ferritin <30 µg/l. Hence, there were 21/91 (23%) with IDA, 6/91 (7%) with possible IDA and 64/91 (70%) with ACD ( Figure 2 ). Among the 351 non-anaemic patients, 23 (6.6%) had serum ferritin <30 µg/l indicating low iron stores and 328 patients had serum ferritin ≥30 µg/l. Overall 18.5% (17/91) of anaemic patients had low red cell indices. Among the anaemic patients, 42.9% (9/21) of those with IDA, 16.7% (1/6) of those with possible IDA, and 9.3% (6/64) of those categorised as having possible ACD had low red cell indices; 4.3% (1/23) of patients without anaemia and low ferritin had low red cell indices.
Estimated glomerular filtration rate <60 ml/min/1.73m 2 was seen in 51.6% (33/64) patients with possible ACD, 33.3% (9/27) of patients with IDA or possible IDA (Table 1 ) and in 17.4% (4/23) of non-anaemic low ferritin patients. Nineteen patients categorised with possible ACD had a ferritin between 30-100 µg/l with a normal CRP, which could still represent absolute iron deficiency in the setting of chronic kidney disease or other chronic disease such as heart failure. Of the 27 ACD patients with serum ferritin between 100-300 µg/l, 26 had a TSAT performed. Eleven (46.2%) of these had a TSAT <20% consistent with functional iron deficiency 11 .
Anaemic patients with IDA and possible ACD were similar in respect to age. However, anaemic patients with IDA had a lower preoperative Hb compared to patients with possible ACD. In addition, a high proportion of IDA patients (48.1%) compared to those with possible ACD (26.6%) were females. Non-anaemic patients with low ferritin had a median age of 65 (54-76) years with 56.5% (13/23) females (Table 1 ).
Discussion
To our knowledge this is the first study to report the aetiology of preoperative anaemia in elective cardiac surgical patients utilising the algorithm published in the 2012 Perioperative module of Australian PBM guidelines. Knowledge of the aetiology of anaemia serves as a guide to further evaluation and optimisation of Hb prior to elective surgery.
Iron deficiency occurs in two main forms. 'Absolute' iron deficiency occurs when total body iron stores are low or depleted. 'Functional' iron deficiency is a disorder in which iron supply to the bone marrow is inadequate despite the presence of normal or increased body iron stores, mediated by elevated hepcidin levels 12 . With regard to absolute iron deficiency, approximately one-third of patients in our study with preoperative anaemia had IDA or possible IDA. Iron deficiency is readily reversible; IV iron allows for rapid and complete replenishment of iron stores; the newer formulations are both safe and cost-effective 13 . Iron replete patients may be better able to mount an erythropoietic response in the postoperative period to reconstitute blood lost during the preoperative (angiography, blood tests etc) and intraoperative period-which may impact on the quality of postoperative recovery. Follow-up to assess the underlying cause of iron deficiency (such as gastrointestinal pathology) also carries a potential health benefit to the patient beyond the planned surgical episode.
Accurate diagnosis of iron deficiency remains challenging. Ferritin can increase independently of iron status in inflammation and chronic disease 14 . Assessment of iron stores directly in bone marrow aspirates is often considered the gold standard but for many reasons is not suitable in routine clinical practice. A study that investigated the relationship between blood tests for iron deficiency and iron stores in bone marrow aspirates of 65 patients undergoing cardiac surgery highlights the potential to underestimate iron deficiency 15 . It found that iron deficiency was common in patients with stable coronary artery disease with normal serum ferritin. In their cohort, which included both anaemic and non-anaemic patients, serum ferritin ≤112 µg/l only had a sensitivity of 51.6% for iron deficiency with a specificity of 78.8%. Soluble transferrin receptor was found to be the best non-invasive test to assess for iron deficiency (sensitivity 66.7%, specificity 96.7%). Whilst bone marrow assessment is often considered a gold standard test, it can be misleading if insufficient material is available 11 . Although this study did not report the quality of samples obtained, it highlights that the use of ferritin and CRP alone in the PBM Guideline template likely underestimates those with absolute iron deficiency in cardiac surgery and potentially other patient groups. Use of soluble transferrin receptor may improve this. However, utility is limited by availability and turnaround times in some laboratories and the absence of standardised cut-offs worldwide 12, 14 .
Studies aimed at optimising red cell mass prior to cardiac surgery are increasing 16 . The ITACS study (Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery) will answer important questions about the utility, cost-effectiveness and safety of preoperative IV iron in patients with anaemia (as defined by WHO) given one to ten weeks prior to elective cardiac surgery 17 . The 7% of patients in the subgroup 'possible IDA' with ferritin between 30-100 µg/l and elevated CRP had either 'absolute' iron deficiency or at the very least, iron stores at the low end of normal. Likewise, 21% of patients with serum ferritin between 30-100 µg/l but with normal CRP are an important group that may also have absolute iron deficiency and be rendered more iron deficient by cardiac surgery, and may fail to recover their Hb back to their usual level in the months postoperatively without iron supplementation. There is potential therefore for misclassification by the template in the PBM guidelines, missing patients with absolute iron deficiency in the setting of subclinical inflammation or chronic disease.
Based on the categories within the PBM Guidelines assessment template, possible ACD was the most common subgroup of preoperative anaemia (70%) in our cohort. Anaemia of chronic disease or inflammation remains ill understood even today and is a common complication of chronic inflammatory diseases (e.g. cancer, rheumatoid arthritis, inflammatory bowel disease and congestive heart failure), sepsis, and chronic renal failure. Features may also exist without a specific disease being identified. The pathophysiological mechanisms of ACD include but are not limited to decreased red cell half-life, impaired responsiveness of erythroid cells to erythropoietin, inhibited proliferation and differentiation of erythroid precursors. Pathological iron homeostasis involving impaired iron absorption, distribution and utilisation are other hallmarks of this condition 18 . The question is what to do with patients that fall into this subgroup? Unlike iron deficiency, their chronic pathology is unlikely to be readily reversible. However, co-existing absolute or functional iron deficiency may respond to iron therapy and this response, as in patients with chronic heart failure, may be independent of Hb 19 . Of patients in our cohort with possible ACD, 46% had iron studies consistent with functional iron deficiency (defined in patients with chronic heart failure as ferritin 100-300 µg/l with TSAT <20%) 16 . The best way to distinguish between absolute and functional iron deficiency in preoperative cardiac surgery patients remains unclear. Differentiation is needed to help guide response to therapy and also for further investigation (e.g. endoscopic investigations to exclude a source of occult gastrointestinal bleeding).
Among patients without anaemia, 6.6% were found to have ferritin <30 µg/l representing low iron stores which will be further depleted by the blood loss associated with cardiac surgery. These patients may then fail to recover their Hb back to normal levels in the months postoperatively without iron therapy. The role of preoperative IV iron supplementation in these patients is unclear and was the subject of a recent trial by Johansson et al 16 .
Serum ferritin is generally considered the most effective test to detect iron deficiency and the diagnostic accuracy can be improved by using a cut-off of 30 µg/l 13 . The preoperative haemoglobin assessment and optimisation template categorises anaemia based on a serum ferritin and CRP, rather than the traditional approach using red cell indices. The finding that a minority of anaemic patients in this study had low red cell indices (including less than half of those with IDA and a ferritin <30 µg/l) supports this approach, as does a recent study in cardiac surgery patients examining the relationship between blood tests for iron deficiency and iron stores in bone marrow aspirates 15 . It is important that clinicians recognise that red cell indices only become abnormal in longstanding iron deficiency and that assessment of iron status is required in all anaemic patients. The template in the PBM guidelines highlights this, serving as an important reminder to clinicians not to limit the assessment of iron status to only those patients with suggestive red cell indices.
Furthermore, the diagnostic accuracy of blood tests for iron deficiency could be influenced by many factors including age, gender, ethnicity, intercurrent illness, recent surgery/ procedures, and chronic disease. In non-haemodialysis chronic kidney disease patients, a ferritin <100 µg/l is associated with a high likelihood of iron deficiency and a potentially good response to IV iron 11 . In patients with chronic heart failure, absolute iron deficiency has been defined as ferritin <100 µg/l 19 . Diagnostic cut-offs specific for preoperative cardiac surgical patients are needed, but for some groups of patients, disease-specific cut-offs may be more applicable.
In our study the vast majority of patients (93%) had a POAC visit within one week of surgery. The anaesthetist has limited time then to optimise Hb and iron stores. Initiation of investigations and coordination of iron infusions require considerable logistical effort. In addition, consensus is lacking regarding the optimal timing of investigations for a patient diagnosed with IDA, as gastrointestinal endoscopy is an invasive procedure requiring procedural sedation and may delay time-critical cardiac surgery. PBM should ideally commence at the time of the decision by the cardiologist, other physician or general practitioner to refer a patient for surgery. Significant progress has been made to educate general practitioners regarding preoperative PBM 20 .
Blood is a finite resource and an effort to reduce its use and misuse requires collaboration among practitioners who provide care throughout the perioperative period. The underlying premise of managing preoperative anaemia is strong in principle, but may not have the same benefit for all. Consider a patient with IDA versus a patient with ACD; does treating preoperative anaemia significantly change postoperative outcome for both? A study by Munoz et al reported that detection and treatment of preoperative anaemia was the least successfully implemented pillar of PBM due to a multitude of factors including urgency of surgery, licencing restrictions on the use of erythropoiesisstimulating agents, and blood loss through preoperative cardiac catheterisation 21 . An audit conducted in the United Kingdom to study transfusion practices in cardiac surgery revealed that only 12% of cardiothoracic surgical units reported an institutional protocol for preoperative optimisation of Hb prior to elective cardiac surgery 22 .
The strengths of our observational study include assessment of patients against a national guideline, the use of tests which are inexpensive and widely available, a large representative sample over two years, and minimal selection bias. This study also has the potential to define various groups for prospective trials of efficacy of iron therapy in cardiac surgery patients. The study's limitations include being a single centre and a retrospective database analysis. We did not collect data regarding comorbidities, current medication including oral over-the-counter iron formulations, or which patients were referred for further evaluation (including investigation by gastrointestinal endoscopy etc). Due to the short time between preoperative assessment and surgery, or urgency of surgery, complete evaluation and optimisation of Hb may not have been possible and was at the discretion of the anaesthetist and referring surgeon.
In conclusion, this study has demonstrated that about one-third of our patients with preoperative anaemia had evidence of iron deficiency and hence a potentially reversible cause of anaemia. There were also a significant number of patients with either limited iron stores (who may be rendered iron deficient by surgery) or inability to utilise available iron (functional iron deficiency). These represent important groups for inclusion in prospective studies. Furthermore, POACs may be able to use this information to better direct resources for investigation and management of anaemia; for example the establishment of a preoperative gastroenterology or haematology referral service. However, PBM pillar one raises many more questions. If outcomes are improved by iron therapy, will these be dependent or independent of the effect on Hb (as seen in patients with chronic heart failure)? What is the minimal time between therapy (e.g. IV iron) and surgery to achieve these outcomes? Despite these current uncertainties, there are important reasons to justify implementation of this pillar of PBM.
